TARS

TARSUS PHARMACEUTICALS INC

TARS·87650L103·US·Common Stock·Healthcare - Biotechnology-13D/G

TARS (TARSUS PHARMACEUTICALS INC) is held by 147 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($242.7M), RTW INVESTMENTS, LP ($211.3M), MORGAN STANLEY ($115M). Net institutional sentiment: Mixed.

147
Holders
(12 Elite)
$2B
Total Value
52% (150)
Consensus
78 buying - 72 selling
13F: Insider & Congress: Updated regularly
TARS

Smart Money Verdict

View all
Loading verdict
Held by 147 funds
12 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Jun 22, 2026 · Activists Aug 13, 2026 · Congress none

ActivistJANUS HENDERSON GROUP Ltd.JANUS HENDERSON GROUP Ltd.6.5%Aug 13, 2026
InsiderARAzamian Bobak R.Sell $281KJun 17, 2026
InsiderARAzamian Bobak R.Sell $335KJun 17, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
3.9M(+8.5%)$242.7M0.0%+32.79%
33
Increased
3.4M(+0.3%)$211.3M1.8%+94.82%
48
Decreased
1.8M(-6.0%)$115M0.0%+120.11%
0
Increased
1.8M(+1.9%)$112.9M0.0%-7.41%
31
Decreased
1.7M(-2.8%)$104.7M0.1%+84.99%
0
Increased
1.4M(+152.8%)$89.8M0.0%+6.15%
48
Decreased
1.2M(-0.1%)$75.1M0.0%+4.91%
0
Decreased
1.1M(-1.4%)$69.6M0.0%+106.84%
0
Increased
1.1M(+9.7%)$67.5M0.0%+134.08%
32
Decreased
947,495(-26.0%)$59.6M0.1%+81.76%
0
Increased
785,808(+5.8%)$49.5M0.0%+68.63%
31
Increased
742,693(+68.9%)$46.7M0.0%+18.42%
43
Decreased
710,559(-10.2%)$44.7M0.0%+38.83%
0
Decreased
672,949(-8.2%)$42.4M0.0%-12.58%
0
Increased
607,272(+21.5%)$38.2M0.1%-10.46%
35
Increased
549,387(+0.7%)$34.6M0.0%+51.51%
29
Unchanged
510,253$32.1M0.0%+29.16%
0
New
427,008$26.9M0.0%+12.25%
40
Increased
386,611(+9.5%)$24.3M0.0%+113.20%
31
Increased
385,137(+14.7%)$24.2M0.0%-5.56%
33

Showing 1-20 of 157

1 / 8
TARSTARSTARSUS PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used